Lymphocytes enter lymph nodes by first adhering to high endothelial venules, an adhesive event mediated by a lectinlike lymphocyte receptor (L-selectin). Previously, it was shown with an in vitro assay that lymphocytes preferentially adhere to myelinrich regions in brain sections. Here, using a recombinant form of L-selectin as an immunohistochemical reagent, we demonstrate potential ligands for L-selectin in myelinated regions of the central but not the peripheral nervous system. Using several antibodies and phorbol ester downmodulation of the receptor, we establish that L-selectin on human lymphocytes has a primary involvement in lymphocyte adherence to the myelinated regions. On mouse lymphocytes, the contribution of Lselectin appears to be partial. These findings raise the possibility that leukocyte targeting to myelin-rich regions, via a L-selectin dependent mechanism, may be a factor in the pathogenesis of certain central nervous system demyelinating dis-
Introduction
Lymphocytes recirculate continuously throughout the body, passing through secondary lymphoid organs such as peripheral lymph nodes (PN)' and Peyer's patches, which are interposed between the blood and lymphatics. The selective migration or homing of blood-borne lymphocytes to lymphoid organs depends on tissue-specific adhesive interactions with specialized endothelial cells (EC) ofhigh endothelial venules (HEV) within the lymphoid organs (1) (2) (3) . In the case ofPN, the adhesion step is mediated by the interaction of a calcium-dependent, lectinlike receptor termed L-selectin (also known as LECAM-1, MEL-14 antigen, PN homing receptor, gp9OMEL, LAM-1, Ly-22, Leu-8, TQ1, and DREG) on the lymphocyte surface (4-1 1) and a carbohydrate-based ligand (12, 12a) expressed by the EC of PN HEV cells. L-Selectin is a member of the "selectin" family of cell-cell adhesion proteins which also includes ELAM-1 (E-selectin) and CD62 (P-selectin) (13). A homing receptor distinct from L-selectin is used by lymphocytes to enter Peyer's patches (14) (15) (16) and another adhesion molecule appears to be involved in migration to chronic inflammatory lesions such as the synovium in rheumatoid arthritis (17) .
The adhesive interactions between lymphocytes and HEV have been studied primarily with the Stamper-Woodruff assay (18) , in which viable lymphocytes attach selectively to HEV structures within cryostat-cut sections of lymphoid organs. In the mouse, the ability of various lymphocyte populations to bind HEV within different lymphoid organs in vitro shows excellent correspondence with their migration to these tissues in vivo (19) . The Stamper-Woodruffassay was recently applied to the study of B cell binding to germinal centers of tonsil, an interaction that may underlie the localization of activated B cells to the follicles of lymphoid organs (20) .
Several years ago, Kuttner and Woodruff employed the same assay to demonstrate that rat peripheral lymphocytes are able to adhere specifically to the white matter, but not to nonmyelinated regions, of both cerebellum and cerebrum (21) Histochemical staining using LEC-IgG. The method for LEC-IgG staining was described in detail elsewhere (24) . Briefly, cryostat-cut sections (10 Mm) were fixed with 0.5% paraformaldehyde in 0.1 M sodium cacodylate (pH 7.3) for 20 min on ice, followed by immersion in 100% methanol with 0.3% H202 for 20 min on ice. The sections were washed in Dulbecco's PBS and incubated for 80 min on ice with 30 ,qg/ml LEC-IgG diluted in 5% normal horse serum and 5% normal rat serum. They were incubated with biotinylated-goat anti-human IgG (Zymed Laboratories, South San Francisco, CA) in PBS containing 5% normal mouse serum followed by an ABC Elite reagent (Vector Laboratories, Inc., Burlingame, CA), and then AEC peroxidase substrate (Biomeda, Foster City, CA). Finally, the sections were counterstained with aqueous hematoxylin (Biomeda) and photographed with a Nikon Optiphot microscope.
In vitro lymphocyte binding assay. Mouse MLN lymphocytes or Jurkat cells ( 1-3 X 106 cells in 100 gAl ofRPMI 1640 supplemented with 5% FCS and 12.5 mM Hepes) were incubated on paraformaldehydefixed tissue sections by a modification of the Stamper-Woodruffassay (27) . Antibodies tested were added to the cell suspension before the incubation. The sections were then fixed in 2.5% glutaraldehyde and stained with toluidine blue. A unit area (UA, 0.032 mm2) was defined with the aid ofan ocular reticle or as a defined myelin strip present on a series of contiguous tissue sections. In assays testing the effects of rat antibodies reactive to mouse L-selectin and LPAM-1, a ratio method was used in which rat lymphocytes (used as an internal control population) were labeled with 60 jg/ml FITC in PBS for 30 min at 370C (28) and mixed with an equal number of mouse lymphocytes for the binding assay. Antibodies that were tested were present continuously during the binding assay. Inhibition of adherence was calculated from the change in the ratio of specifically bound mouse to rat cells.
Results
We extended the basic observation ofKuttner and Woodruffto other species by showing that mouse MLN lymphocytes (Fig. 1  a) and human Jurkat cells (Fig. 1 c) attach to the white matter tract of mouse cerebellum while exhibiting very limited binding to the grey matter region (granular layer) or to the dendritic region (molecular layer). Equally selective binding was also ob- Data are reported as mean percent inhibition ofbinding (±SEM) relative to controls (no antibody or EGTA). Three to five replicate sections were used for each condition. Negative values denote percent increase of cell binding. In experiment 1, the ratio method was used with an internal standard offluorescein-labeled rat lymphocytes (see Methods). The antibodies were used at the following concentrations: MEL-14, 5 tg/ml; PolyMEL serum, 1:10; LAM1.4, 1:100; TQ1, 10 ug/ml. Anti-human #B, 2, and a4 were used at a saturating concentration for Jurkat cells as established by flow cytometry analysis. EGTA was used at 10 mM. The antibodies and EGTA were added to the cells immediately before incubation of the cells with the tissue sections and were present continuously during the binding assay. The control level of binding ranged from 100 to 300 cells per UA in the different experiments. MLNL denotes mesenteric lymph node lymphocytes. * In a separate experiment, EGTA produced 88 ± 3% inhibition of mouse lymphocyte binding to mouse cerebellar white matter.
served to white matter tracts as compared to the grey matter regions ofthe spinal cord (not shown). Consistent with a possible role ofa calcium-dependent adhesion molecule in the interaction, the addition ofEGTA greatly reduced (> 80%) the binding of mouse lymphocytes to cerebellar white matter and completely prevented (> 96%) the adherence ofJurkat cells (Fig. 1,  b and d, Tables I and II) . To determine if the myelinated regions contained potential ligands for L-selectin, brain and spinal cord sections were stained with LEC-IgG. As shown in Fig.  2 , the myelin-rich white matter tracts of both cerebellum and spinal cord exhibited specific staining. In contrast, regions having few or no myelinated fibers, such as the granular and molecular layers of the cerebellum and the grey matter of the spinal cord, were negative. In some instances, Purkinje cell bodies were slightly positive. In agreement with the known calcium dependency of L-selectin (29, 30) , the addition of EGTA to LEC-IgG greatly reduced staining of the myelinated regions as was previously observed for staining of PN HEV (24) . Strikingly, the staining of myelinated fiber tracts appeared to be restricted to the CNS, because LEC-IgG reactivity was not detected on the nerve root adjacent to the white matter of spinal cord (Fig. 2 c) or on the sciatic nerve (not shown).
To determine directly whether L-selectin on lymphocytes contributed to their binding to myelinated regions, we employed monoclonal and polyclonal antibodies against L-selectin. MEL-14 is a well characterized monoclonal antibody which recognizes mouse L-selectin and completely blocks mouse lymphocyte binding to PN HEV (4) . As shown in Fig. 3 , MEL-14 produced a partial inhibition (30%) ofmouse lymphocyte binding to cerebellum white matter (mouse or human), whereas the binding to PN HEV was almost completely eliminated. Anti-T200, a class-matched antibody reactive with the lymphocyte common antigen (CD45), had no effect on binding to either PN HEV or cerebellar myelin. Whereas MEL-14 inhibited -30% (ranging from 20 to 50% in different experiments) of lymphocyte binding to myelinated regions, EGTA caused > 80% inhibition (Fig. 1, Table I ). PolyMEL is a rabbit polyclonal antiserum produced against murine L-selectin that blocks adherence oflymphocytes from mouse, rat, and human origin to PN HEV (25) . When tested on mouse lymphocyte binding to myelinated regions of cerebellum, PolyMEL also produced a partial inhibitory effect of 50% (Table I) .
TQ1 and LAM 1.4 are recently described monoclonal antibodies that react with human L-selectin (31) and effectively interfere with lymphocyte attachment to PN HEV. In contrast to the partial effects noted above with anti-L-selectin reagents on mouse lymphocytes, TQ1 blocked (> 90%) the binding of both a Jurkat T cell line and human PBL to cerebellar myelin to the same extent as EGTA (Table I) effects were observed with TQ1, whether the cerebellar sections were of human or mouse origin. In addition, LAM 1.4 and PolyMEL produced almost complete inhibition of Jurkat cell binding to cerebellar myelin (Table I) .
Several integrins, in particular VLA-4 (a4,81), LPAM-l (asflp), and LFA-l (afi2), are known to participate in lymphocyte adhesive interactions to a variety of cells including other lymphocytes, endothelial cells, follicular dendritic cells, fibroblasts, and keratinocytes (16, 20, 32, 33) . Therefore, to determine whether the observed inhibitory effects were restricted to anti-L-selectin reagents, function-blocking antibodies against a4, aI, and #2 were tested for their effects on mouse lymphocyte, human PBL, and human Jurkat cell binding to cerebellar myelin. As shown in Table I , none of these antibodies produced inhibition when tested at saturation.
Further evidence for the involvement of L-selectin in myelin binding came from phorbol ester studies. PMA treatment of human lymphocytes is known to cause a rapid and almost complete shedding of L-selectin from the cell surface, which is presumed to be due to proteolytic cleavage (31). We confirmed this observation for the Jurkat cells by FACS analysis with an anti L-selectin mAb (i.e., TQl). After down modulation of Lselectin, binding to cerebellar myelin tract and to PN HEV were both drastically reduced (Table II) .
Discussion
The present results indicate a role for L-selectin in the in vitro attachment of lymphocytes to myelinated regions of CNS. Ligand sites for L-selectin are concentrated in white matter regions of CNS, where myelinated axons are abundant. In the case of mouse lymphocytes, the contribution of L-selectin appears to be partial in view ofthe incomplete inhibition by either a monoclonal or a polyclonal antibody. The finding that mouse lymphocyte binding is greatly reduced by EGTA suggests the possible participation of other calcium-dependent re- Inhibition ofadherence was calculated as the change in the ratio of HEV-or myelin-bound mouse to rat cells. Anti-T200 at 500 ng/ml did not affect the lymphocyte binding to either PN HEV or cerebellum myelin (< 5% change).
ceptors on the same cells or on distinct cell populations. However, in the case of human lymphocytes, L-selectin appears to play a dominant role in attachment to white matter because each ofthree independent antibodies against this molecule virtually eliminates attachment. Moreover, PMA-induced downregulation of surface L-selectin is completely correlated with the loss of attachment activity. L-Selectin, like the other two members of the selectin family (34), depends on lectin activity for its adhesive function. HEV-associated, biological ligands for L-selectin in lymph nodes have been identified as two sulfated, sialylated, and fucosylated glycoproteins (12) . However, in addition to these biological ligands, L-selectin can bind to several related carbohydrate structures from a variety of natural sources (35) . It (39, 40) . Moreover, the neuroantigen-specific lymphocytes are predominantly restricted to perivascular localizations, whereas the infiltrating lymphocytes contiguous with the actual lesions are of unknown antigen specificity (39) . These findings in EAE, as well as observations in other demyelinating diseases (41) (42) (43) , suggest that the demyelination process itself may involve lymphocytes lacking immune reactivity to neuroantigens, although the entry of these cells into the brain may be orchestrated by neuroantigen-specific lymphocytes (39, 43) . The present demonstration that L-selectin can mediate lymphocyte attachment to myelinated tracts suggests a potential mechanism for the targeting oflymphocytes (irrespective oftheir antigen specificity) as well as other leukocytes possessing L-selectin (44, 45) to myelinated axons ofthe CNS. Once proximity were established via a L-selectin-dependent adhesion mechanism, selective damage to myelinated cells could result from a process of cell-mediated cytotoxicity or from the local release of cytokines, proteases, or free radicals. These models presuppose that the leukocytes are activated as cytotoxic or cytokine-secreting cells before their association with myelin or that they become fully activated as a consequence ofthe association. The restriction of ligand sites to CNS as opposed to the PNS white matter may offer an explanation of why many demyelinating diseases selectively affect the CNS. The availability of a wide variety of reagents (e.g., antibodies, carbohydrates, LEC-IgG) that block the interaction of L-selectin with its ligands should allow further investigation of the possible role of this widelydistributed adhesion receptor in mediating leukocyte adhesion to myelinated nerves in vivo and in contributing to pathological demyelination reactions. In this regard, it is noteworthy that treatment of rats with fucoidin or mannose-6-phosphate, two carbohydrate-based inhibitors of L-selectin, have been reported to prevent or delay the induction of adoptively transferred EAE in rats (46, 47) .
